SE464083B - Etylendiaminmonoamider av vissa heterocykliska karboxylsyror, foerfarande foer framstaellning av dessa och laekemedel - Google Patents

Etylendiaminmonoamider av vissa heterocykliska karboxylsyror, foerfarande foer framstaellning av dessa och laekemedel

Info

Publication number
SE464083B
SE464083B SE8504014A SE8504014A SE464083B SE 464083 B SE464083 B SE 464083B SE 8504014 A SE8504014 A SE 8504014A SE 8504014 A SE8504014 A SE 8504014A SE 464083 B SE464083 B SE 464083B
Authority
SE
Sweden
Prior art keywords
hydrogen
aminoethyl
halogen
carboxamide
lower alkyl
Prior art date
Application number
SE8504014A
Other languages
English (en)
Swedish (sv)
Other versions
SE8504014L (sv
SE8504014D0 (sv
Inventor
R Imhof
E Kyburz
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH4132/84A external-priority patent/CH661043A5/de
Priority claimed from CH2404/85A external-priority patent/CH664755A5/de
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of SE8504014D0 publication Critical patent/SE8504014D0/xx
Publication of SE8504014L publication Critical patent/SE8504014L/xx
Publication of SE464083B publication Critical patent/SE464083B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/84—Nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/06—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/18—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Furan Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicinal Preparation (AREA)
  • Pyrrole Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
SE8504014A 1984-08-29 1985-08-28 Etylendiaminmonoamider av vissa heterocykliska karboxylsyror, foerfarande foer framstaellning av dessa och laekemedel SE464083B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH4132/84A CH661043A5 (en) 1984-08-29 1984-08-29 Ethylenediamine monoamide derivatives
CH2404/85A CH664755A5 (de) 1985-06-05 1985-06-05 Aethylendiaminmonoamid-derivat.

Publications (3)

Publication Number Publication Date
SE8504014D0 SE8504014D0 (sv) 1985-08-28
SE8504014L SE8504014L (sv) 1986-03-01
SE464083B true SE464083B (sv) 1991-03-04

Family

ID=25690366

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8504014A SE464083B (sv) 1984-08-29 1985-08-28 Etylendiaminmonoamider av vissa heterocykliska karboxylsyror, foerfarande foer framstaellning av dessa och laekemedel

Country Status (28)

Country Link
US (1) US4764522A (mo)
JP (2) JPH0764817B2 (mo)
KR (1) KR920007269B1 (mo)
AR (1) AR244209A1 (mo)
AT (1) AT391694B (mo)
AU (1) AU582381B2 (mo)
BE (1) BE903110A (mo)
BG (1) BG60401B1 (mo)
CA (1) CA1261335A (mo)
DE (1) DE3530046C2 (mo)
DK (1) DK162888C (mo)
ES (2) ES8705372A1 (mo)
FI (1) FI83511C (mo)
FR (1) FR2569694B1 (mo)
GB (1) GB2163746B (mo)
GR (1) GR852071B (mo)
HU (1) HU197309B (mo)
IE (1) IE58788B1 (mo)
IL (1) IL76176A (mo)
IT (1) IT1190385B (mo)
LU (1) LU86049A1 (mo)
MC (1) MC1696A1 (mo)
NL (1) NL193583C (mo)
NO (1) NO169711C (mo)
NZ (1) NZ213193A (mo)
PH (1) PH22813A (mo)
PT (1) PT81041B (mo)
SE (1) SE464083B (mo)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5204482A (en) * 1988-07-28 1993-04-20 Hoffman-Laroche Inc. Compounds for treating and preventing cognitive diseases and depression and methods of making same
EP0352581A3 (de) * 1988-07-28 1990-07-04 F. Hoffmann-La Roche Ag Aethylendiaminmonoamid-Derivate
CA2008878C (en) * 1989-02-28 2003-01-21 Michelangelo Scalone Process for preparing pyridine-2-carboxamides
EP0451790A1 (de) * 1990-04-12 1991-10-16 Hoechst Aktiengesellschaft 3,5-disubstituierte 2-Isoxazoline und Isoxazole, Verfahren zu deren Herstellung, diese enthaltende Mittel und ihre Verwendung
JPH04295470A (ja) * 1991-03-22 1992-10-20 Wakamoto Pharmaceut Co Ltd モノアミンオキシダーゼ−ｂ酵素阻害活性を有する１，２，４−オキサジアゾール誘導体及びその製造法
US5545658A (en) * 1991-03-26 1996-08-13 Hoffman-La Roche Inc. Amino acid derivatives
RU2097378C1 (ru) * 1991-03-26 1997-11-27 Ф.Хоффманн-Ля Рош Аг ПРОИЗВОДНЫЕ N-АЦИЛ- α -АМИНОКИСЛОТЫ ИЛИ ИХ ФИЗИОЛОГИЧЕСКИ ПРИЕМЛЕМЫЕ СОЛИ, ПРОСТЫЕ ИЛИ СЛОЖНЫЕ ЭФИРЫ, АМИДЫ ИЛИ ГИДРАТЫ И КОМПОЗИЦИЯ ИНГИБИРУЮЩАЯ СВЯЗЫВАНИЕ АДГЕЗИВНЫХ ПРОТЕИНОВ С ТРОМБОЦИТАМИ И АГРЕГАЦИЮ ТРОМБОЦИТОВ
FR2803592A1 (fr) * 2000-01-06 2001-07-13 Aventis Cropscience Sa Nouveaux derives de l'acide 3-hydroxypicolinique, leur procede de preparation et compositions fongicides les contenant.
CN102526045A (zh) * 2001-12-06 2012-07-04 法布罗根股份有限公司 提高内源性红细胞生成素(epo)的方法
US6667327B2 (en) * 2002-02-04 2003-12-23 Hoffmann-La Roche Inc. Pyridine amido derivatives
ATE411027T1 (de) * 2003-10-23 2008-10-15 Hoffmann La Roche Benzazepin-derivate als mao-b-hemmer
US8138209B2 (en) * 2005-07-13 2012-03-20 Jenrin Discovery, Inc. Substituted picolinamides as MAO-B inhibitors useful for treating obesity
WO2008010794A1 (en) * 2006-07-18 2008-01-24 Renaissance Medicine, Llc Pharmaceutical preparations of crystalline lazabemide
WO2008010796A1 (en) * 2006-07-18 2008-01-24 Renaissance Medicine, Llc Process for preparing pyridine-2-carboxamides and intermediates therefor
FR2904317A1 (fr) * 2006-07-27 2008-02-01 Inst Nat Sante Rech Med Analogues d'halogenobenzamides marques a titre de radiopharmaceutiques
EP2085390A1 (en) 2008-01-31 2009-08-05 Institut National De La Sante Et De La Recherche Medicale (Inserm) Labelled analogues of halobenzamides as multimodal radiopharmaceuticals and their precursors
WO2011028740A1 (en) * 2009-09-03 2011-03-10 Glaxo Group Limited ENaC BLOCKERS
SMT202400092T1 (it) 2013-06-13 2024-05-14 Akebia Therapeutics Inc Composizioni e metodi per il trattamento dell'anemia
PL3277270T3 (pl) 2015-04-01 2022-02-14 Akebia Therapeutics, Inc. Kompozycje i sposoby leczenia niedokrwistości
WO2019028150A1 (en) 2017-08-01 2019-02-07 Akebia Therapeutics, Inc. COMPOSITIONS FOR USE IN METHODS OF TREATING HEMOGLOBINOPATHIES

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB451304A (en) * 1934-07-07 1936-08-04 Karl Merck Process for the manufacture of new derivatives of pyrazinemonocarboxylic acid
DE1217385B (de) * 1962-11-09 1966-05-26 J. R. Geigy A.-G., Basel (Schweiz) Verfahren zur Herstellung von neuen Picolinsäurederivafen
NL6707566A (mo) * 1966-08-17 1968-02-19
GB1509527A (en) * 1974-06-05 1978-05-04 Ici Ltd 1-(aryl-or heteroaryl)oxy-3-(substituted-amino)propan-2-ol derivatives processes for their manufacture and pharmaceutical compositions containing them
US4041032A (en) * 1974-01-16 1977-08-09 Yamanouchi Pharmaceutical Co., Ltd. Pyrazine derivatives
GB1509300A (en) * 1975-12-05 1978-05-04 Ici Ltd Ethanolamine derivatives
DE3239573A1 (de) * 1981-10-28 1983-05-19 Byk Gulden Lomberg Chemische Fabrik Gmbh, 7750 Konstanz Substituierte picolinsaeuren, verfahren zu ihrer herstellung, ihre verwendung und sie enthaltende arzneimittel
IE54220B1 (en) * 1981-12-23 1989-07-19 Ici Plc Phenol esters
CH653670A5 (de) * 1983-03-03 1986-01-15 Hoffmann La Roche Benzamid-derivate.

Also Published As

Publication number Publication date
LU86049A1 (de) 1986-09-11
JPH0825879B2 (ja) 1996-03-13
US4764522A (en) 1988-08-16
KR920007269B1 (ko) 1992-08-29
DK162888C (da) 1992-05-11
MC1696A1 (fr) 1986-07-18
JPH07300417A (ja) 1995-11-14
IT1190385B (it) 1988-02-16
FI83511B (fi) 1991-04-15
ATA251585A (de) 1990-05-15
BE903110A (fr) 1986-02-24
DE3530046C2 (de) 1997-12-04
GB2163746A (en) 1986-03-05
IE58788B1 (en) 1993-11-17
NO169711C (no) 1992-07-29
DK162888B (da) 1991-12-23
SE8504014L (sv) 1986-03-01
AT391694B (de) 1990-11-12
AU582381B2 (en) 1989-03-23
PT81041B (pt) 1988-01-22
SE8504014D0 (sv) 1985-08-28
AR244209A1 (es) 1993-10-29
PH22813A (en) 1988-12-27
BG96645A (bg) 1993-12-24
FR2569694A1 (fr) 1986-03-07
FI83511C (fi) 1991-07-25
IL76176A (en) 1989-02-28
IE852118L (en) 1986-02-28
FR2569694B1 (fr) 1991-05-03
ES552399A0 (es) 1987-11-01
NO169711B (no) 1992-04-21
FI853140L (fi) 1986-03-01
CA1261335A (en) 1989-09-26
GB2163746B (en) 1988-06-22
FI853140A0 (fi) 1985-08-15
JPS6160657A (ja) 1986-03-28
DK391485A (da) 1986-03-01
KR870002078A (ko) 1987-03-30
HU197309B (en) 1989-03-28
GB8521358D0 (en) 1985-10-02
ES546482A0 (es) 1987-05-01
ES8705372A1 (es) 1987-05-01
IT8521865A0 (it) 1985-08-05
NL193583C (nl) 2000-03-02
NL193583B (nl) 1999-11-01
GR852071B (mo) 1985-12-24
DE3530046A1 (de) 1986-03-13
PT81041A (en) 1985-09-01
NO853390L (no) 1986-03-03
NL8502374A (nl) 1986-03-17
BG60401B1 (en) 1995-02-28
AU4663685A (en) 1986-03-06
NZ213193A (en) 1989-10-27
JPH0764817B2 (ja) 1995-07-12
DK391485D0 (da) 1985-08-28
HUT38317A (en) 1986-05-28
IL76176A0 (en) 1985-12-31
ES8800158A1 (es) 1987-11-01

Similar Documents

Publication Publication Date Title
JP5376956B2 (ja) デュシェンヌ型筋ジストロフィーの治療
AU707751B2 (en) Substituted 2,4-imidazolidinedione compounds as pharmaceutical active ingredients
US10752617B2 (en) Indazole sulfonamide derivatives as inverse agonists of retinoid-related orphan receptor gamma (ROR gamma (T))
DE60029235T2 (de) Fab-i-hemmer
NL193583C (nl) Ethyleendiaminemonoamidederivaten, werkwijzen ter bereiding daarvan, alsmede farmaceutische preparaten en de toepassing daarvan.
TWI313266B (en) Thiazoline derivatives and pharmaceutical composition containing the same
JP2011063620A (ja) ピペリジンおよびピペラジン誘導体
WO2010075290A1 (en) Unsaturated heterocyclic inhibitors of necroptosis
JPWO2003033493A1 (ja) ペルオキシソーム増殖剤応答性受容体δの活性化剤
WO2005073165A1 (ja) アミド誘導体及びその製造方法ならびにその殺虫剤としての使用方法
EP0352581A2 (de) Aethylendiaminmonoamid-Derivate
KR20010021538A (ko) 트리아졸 화합물 및 도파민-ｄ₃-리간드로서의 그의 용도
FR2967674A1 (fr) Derives d'heteroarylsulfonamides, leur preparation et leur application en therapeutique humaine
NO180678B (no) N-substituerte heterocykliske forbindelser og farmasöytisk preparat
SE466309B (sv) 1-pyrimidinyloxi-3-hetarylalkylamino-2-propanoler, farmaceutisk komposition och framstaellning daerav
US5204482A (en) Compounds for treating and preventing cognitive diseases and depression and methods of making same
US20250145561A1 (en) 4-substituted-phenyl acetamides and arylureas as agonists for the orphan receptor gpr88
US7176310B1 (en) Pyrimidinecarboxamide derivatives and their use as anti-inflammatory agents
HUT52038A (en) Process for producing alpha-cyano-beta-oxo-propion-amides
CN102603553B (zh) 具有协同抗真菌作用的化合物及其在药学中的用途
CN118541348A (zh) 4-取代-苯基乙酰胺和芳基脲作为孤儿受体gpr88的激动剂
SE466447B (sv) N-aminoetylbensamidderivat samt farmaceutiska preparat daerav
CZ303407B6 (cs) Amidy (R)-enantiomeru 2-arylpropionových kyselin, zpusob jejich výroby a farmaceutický prostredek s jejich obsahem
SE460419B (sv) Substituerade 1-pyridyloxi-3-indolylalkylamino-2-propanoler, foerfarande foer framstaellning av dessa och en farmaceutisk komposition
DE60318459T2 (de) Neue verbindungen

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8504014-5

Format of ref document f/p: F

NUG Patent has lapsed